Clinical Trial Update: HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Virginia evaluating HPV DNA-guided radiotherapy to de-intensify treatment for oropharyngeal squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oropharynx

Snippet

Sponsor: University of Virginia | Conditions: Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Status: RECRUITING